Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2014
12/04/2014US20140357652 Rho kinase inhibitors
12/04/2014US20140357649 Phenyl(oxy/thio)alkanol Derivatives
12/04/2014US20140357644 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
12/04/2014US20140357643 Derivatives of Betulin
12/04/2014US20140357629 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
12/04/2014US20140357599 Novel urea and thiourea derivatives
12/02/2014US8901314 Substituted pyrazoles as N-type calcium channel blockers
12/02/2014US8901295 Inhibitors of cyclophilins and uses thereof
12/02/2014US8901147 Bi-heteroaryl compounds as Vps34 inhibitors
12/02/2014US8901146 Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
12/02/2014US8901141 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
12/02/2014US8901138 Sulfoximine substituted quinazolines for pharmaceutical compositions
12/02/2014US8901136 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
12/02/2014US8901121 Metalloenzyme inhibitor compounds
12/02/2014US8901120 Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase
12/02/2014US8901119 Peptide deformylase inhibitors
12/02/2014US8901116 Method for treating pain, anxiety or depression using carbamoyloxy alkanoyl piperazine compound
12/02/2014US8900797 Developable bottom anti-reflective coating
12/02/2014US8900785 Charge control agent and toner using the same
12/02/2014US8900638 Solid preparation comprising alogliptin and metformin hydrochloride
11/2014
11/27/2014US20140350251 Herbicidal pyrimidines
11/27/2014US20140350248 Chemical entities and therapeutic uses thereof
11/27/2014US20140350038 Rilpivirine hydrochloride
11/27/2014US20140350036 Agents that prevent or repair skin damage
11/27/2014US20140350033 Ant-ligands molecules and biological applications
11/27/2014US20140350032 Propenoate derivatives of betulin
11/27/2014US20140350024 Antimicrobial agents
11/27/2014US20140350012 Piperidine/piperazine derivatives
11/27/2014US20140350007 Crystalline forms of tricyclic compound acid salt or hydrate thereof, and method for making thereof
11/27/2014US20140349997 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/27/2014US20140349996 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/27/2014US20140349992 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
11/25/2014US8895737 Process for preparing antiviral compounds
11/25/2014US8895736 Synthesis of substituted 2-nitromalonaldehyde intermediates toward the preparation of polyaza-adamantanes
11/25/2014US8895734 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
11/25/2014US8895574 Benzyloxypyrimidine derivative, agricultural/ horticultural insecticide comprising derivative and method for using same
11/25/2014US8895573 Phenoxy-substituted pyrimidines as opioid receptor modulators
11/25/2014US8895572 Fused heterocyclic indane carboxamide CGRP receptor antagonists
11/25/2014US8895566 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors
11/25/2014US8895565 Heterocyclic compound and use of the same
11/25/2014US8895561 Compounds and methods for treating candidiasis and aspergillus infections
11/25/2014US8895548 Pharmaceutical composition for treating alzheimer's disease
11/25/2014US8895474 Herbicidally active cyclopentanediones and derivatives thereof, and their use in controlling weeds
11/20/2014US20140343079 Therapeutic compounds
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/18/2014US8889906 Tetralin and indane derivatives and uses thereof
11/18/2014US8889860 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing
11/18/2014US8889840 Vascular leakage inhibitor
11/18/2014US8889741 Cycloalkane derivatives
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889698 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2014US8889695 Quinazolinone compounds
11/18/2014US8889694 N-alkoxyamides of 6-(substituted phenyl)-4-aminopicolinates and 2-(substituted phenyl)-6-amino-4-pyrimidinecarboxylates and their use as selective herbicides for crops
11/13/2014US20140336383 Prolyl hydroxylase inhibitors
11/13/2014US20140336377 Arylamide derivatives as ttx-s blockers
11/13/2014US20140336208 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
11/13/2014US20140336199 Compounds and Pharmaceutical Compositions for Treating Disorders Associated With the 5-HT1A and 5-HT2A Receptors
11/13/2014US20140336194 Method of treating contrast-induced nephropathy
11/13/2014US20140336185 Novel glp-1 receptor stabilizers and modulators
11/13/2014US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
11/11/2014US8884012 Dye compound and method of making the compound
11/11/2014US8884008 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
11/11/2014US8883826 Alkynyl derivatives as modulators of metabotropic glutamate receptors
11/11/2014US8883810 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
11/11/2014US8883809 Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof
11/11/2014US8883808 Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy
11/11/2014US8883801 Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
11/11/2014US8883798 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof
11/11/2014US8883797 Metalloenzyme inhibitor compounds
11/11/2014US8883793 Tubulin inhibitors and methods of using the same
11/11/2014US8883786 Glucocorticoid receptor antagonists
11/11/2014US8883759 Anti-tumor effect potentiator
11/11/2014US8883688 Arylalkyl esters of 4-amino-6-(substituted phenyl)-picolinates and 6-amino-2-(substituted phenyl)-pyrimidinecarboxylates and their use as selective herbicides for crops
11/11/2014US8883037 Chiral compounds, cholesteric and ferroelectric liquid crystal compositions comprising these chiral compounds, and liquid crystal displays comprising these liquid crystal compositions
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/06/2014US20140329821 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
11/06/2014US20140329816 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140329805 Dual small molecule inhibitors of cancer and angiogenesis
11/06/2014US20140329798 Substituted cyclopropyl compounds useful as gpr119 agonists
11/06/2014US20140329795 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/04/2014US8877934 N-heteroaryl compounds
11/04/2014US8877926 Process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives
11/04/2014US8877925 2,6-dihalo-5-alkoxy-4-substituted-pyrimidines, pyrimidine-carbaldehydes, and methods of formation and use
11/04/2014US8877785 Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
11/04/2014US8877767 Polymorphs of methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phyenyl}-3-methoxyacrylate
11/04/2014US8877766 Neuroprotective multifunctional antioxidants and their monofunctional analogs
11/04/2014US8877765 Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer
11/04/2014US8877763 Substituted pyridopyrimidine compounds and their use as FLT3 inhibitors
11/04/2014US8877754 Compounds, pharmaceutical compositions and uses thereof
11/04/2014US8877741 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
11/04/2014US8877734 Seleny-methyluracil compounds, radiosensitizer and pharmaceutical composition using them
10/2014
10/30/2014US20140323509 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
10/30/2014US20140323486 Heterocyclic urea compounds
10/30/2014US20140323467 Therapeutic compounds and compositions
10/30/2014US20140323464 Kinase inhibitors
10/30/2014US20140323418 Selective kinase inhibitors
10/28/2014US8871789 Method of preventing or treating viral infection
10/28/2014US8871785 Antiviral phosphonate analogs
10/28/2014US8871777 Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
10/28/2014US8871776 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 427